In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors-Reference-Cited by-同舟云学术

In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors

Published:2000-09 Issue:2 Volume:109 Page:155-163
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Sacerdote Paola,Massi Paola,Panerai Alberto E,Parolaro Daniela

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference28 articles.

1. Effects of tramadol on experimental inflammation;Bianchi;Fundam. Clin. Pharmacol.,1999

2. Phospholipase participation in cannabinoid-induced release of free arachidonic acid;Burstein;Biochem. Pharmacol.,1994

3. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease;Cabral;J. Neuroimmunol.,1998

4. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of D9-tetrahydrocannabinol-induced responses and apparent agonistic activity;Compton;J. Pharmacol. Exp. Ther.,1996

5. Cannabinoid receptor proteins are increased in Jurkat, human T-cell lines after mitogen stimulation;Daaka;J. Pharmac. Exp. Ther.,1996

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating endocannabinoid levels in SARS-CoV-2 infection and their potential role in the inflammatory response;Scientific Reports;2024-08-22

2. Cannabinoids and triple-negative breast cancer treatment;Frontiers in Immunology;2024-08-08

3. Pharmacological blockade of cannabinoid receptor 2 signaling does not affect LPS/IFN-γ-induced microglial activation;Scientific Reports;2023-07-10

4. N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R);European Journal of Medicinal Chemistry;2023-02

5. Cannabinoid receptor 1 positive allosteric modulator (GAT229) attenuates cisplatin-induced neuropathic pain in mice;Saudi Pharmaceutical Journal;2023-02